51 - 60 of 145
This study is looking to recruit CHOP patients 5-30 years old with suspected/ confirmed bone sarcomas. The study is looking to evaluate a new MRI technique to evaluate bones and any mass in them.
The purpose of this research study is to collect information over time in juvenile SpA and back pain patients.
This study will take the patients white blood cells - T cells - and change them to turn against the cancer.
This research study is looking at risk factors for developing Thoracic Insufficiency in children with Larsen's Syndrome.
While recent research has demonstrated that whole genome sequencing is a powerful first-line diagnostic tool, important questions remain around its long-term impact on downstream clinical management approaches.
This study aims to collect data from patients seen at CHOP, CHOP's 3550 Market St. primary care location, Penn, or from the surrounding communities.
The purpose of this study is to learn how to monitor heart health in children and teens with lupus.
The LUNA 3 study is for teenagers and adults (ages 12 and up) with primary immune thrombocytopenia (ITP) for which standard medications are no longer working. The goal of the study is to see if the study drug, Rilzabrutinib can safely increase platelet counts and improve symptoms for people with ITP. Rilzabrutinib is an investigational medication designed to stop your immune system from destroying your platelets. You may be able to join the study if you are:
- 12 years of age or older.
- Diagnosed with primary ITP for at least 6 months for ages 12 through 17 or for at least 3 months for ages 18 and up.
- Have taken IVIg or steroids, but they are no longer working.
- Have platelet counts of less than 30,000.
Other study requirements will apply.
Collect data and blood samples to make observations and determinations about rate and severity of graft-versus-host disease in HCT patients.